Latest News

Core & Main (NYSE:CNM) has appointed former American Water Works CEO M. Susan Hardwick to its board, effective April 1. The company has restructured key governance roles, including a new board chair and a new audit committee chair. The longstanding executive chair has retired as part of the succession changes. Core & Main, trading at $49.4, is adjusting its leadership structure after a 3-year return of 121.8% and a 1-year return of 0.0%. The share price has seen a 2.3% decline over the past...

Investors may be asking whether SBM Offshore at €34.62 is still offering value after its strong run, or if most of the opportunity is already priced in. The stock shows a 0.0% return over the last 7 days, 6.3% over 30 days, 40.3% year to date and 85.7% over 1 year, with a 3 year return of 202.9% and 5 year return of 197.1%, which has put it firmly on many investors' radars. Recent coverage around SBM Offshore has focused on its role in the energy services space and how investors are reacting...

Ocugen (NasdaqCM:OCGN) completed enrollment and dosing early in its pivotal Phase 2/3 GARDian3 trial for OCU410ST. The trial evaluates a one time gene therapy candidate for Stargardt disease, a severe inherited retinal disorder with no approved treatments. This is Ocugen's second late stage clinical program and aligns with its stated goal to submit multiple BLAs by 2028. For readers tracking gene therapy names, Ocugen sits at the intersection of rare ophthalmology and inherited retinal...

Generation Investment Management has already exited its position in Jones Lang LaSalle (JLL), citing rising competition and a belief that the company no longer stands out within commercial real estate services, while JLL’s own recent report underscores a global shortage of premium, post-2020 office space. This combination of an investor stepping back amid competitive pressures and JLL highlighting scarcity in top-tier real estate stock raises important questions about how the company’s...

AIA Group has created a new Technology, Operations and Data Committee at board level. The board has reshuffled existing committees and widened leadership mandates. These governance changes focus on digital capabilities, operational oversight and executive development. AIA Group (SEHK:1299) is drawing attention for moves in its boardroom rather than its share price alone. The stock last closed at HK$87.5, with a 49.3% return over the past year and 13.0% over three years. Against that...

Nuobikan Artificial Intelligence Technology (Chengdu) (SEHK:2635) has just reported FY 2025 results with first half revenue of C¥231.6 million and basic EPS of C¥0.12, set against trailing 12 month revenue of C¥498.2 million and EPS of C¥3.45. The company has seen revenue move from C¥363.7 million to C¥498.2 million over the trailing periods, with EPS shifting from C¥0.28 to C¥3.45. This puts the latest release in the context of a steadily larger top line but changing earnings power. For...

Wondering if Meritage Homes at around US$61.84 is a bargain or fairly priced? This article focuses on what the current share price might be telling you about value. The stock has returned 1.5% over the last 7 days, while the 30 day return sits at an 18.0% decline and the one year return is a 10.7% decline, despite 3 year and 5 year returns of 12.0% and 39.0% respectively. Recent attention on Meritage Homes has centered on its share price performance and how housing related names are being...

Marsh & McLennan Companies (NYSE:MRSH) has announced a leadership transition at its consulting and risk businesses. Ted Moynihan has been named President and CEO of Marsh Management Consulting and Oliver Wyman. Nick Studer has been appointed President and CEO of Marsh Risk. For investors tracking NYSE:MRSH, these moves come with the shares at $173.45 and a mixed return profile, including a 7.9% gain over 3 years and 49.6% over 5 years, alongside a 27.7% decline over the past year. The...

If you are wondering whether Truist Financial's current share price reflects its underlying worth, the recent mix of returns provides plenty to think about. The stock last closed at US$45.97, with a 1.4% gain over 7 days, a 6.8% decline over 30 days, a 7.6% decline year to date, a 17.5% return over 1 year, a very large 69.3% return over 3 years, and a 1.6% decline over 5 years. Recent headlines around Truist Financial have focused on the broader banking sector, regulatory scrutiny, and...

On March 26, 2026, Ingevity Corporation entered into a Second Amended and Restated Credit Agreement that extended the maturity of its revolving credit facility by five years, reduced total commitments from US$1 billion to US$750 million, and repaid US$512.1 million of outstanding revolving loans. This move reshapes Ingevity’s financial toolkit, signaling an emphasis on disciplined liquidity management, lower standby borrowing capacity, and a refreshed banking agreement with updated covenant...

Zhongyuan Bank (SEHK:1216) has posted its FY 2025 numbers with first half revenue of C¥5.5b and basic EPS of C¥0.0517, setting the tone for how you assess the latest move in the share price at C¥0.33. Over the past few periods the bank has seen revenue shift from C¥5.9b in 1H 2024 to C¥7.2b in 2H 2024 and C¥5.5b in 1H 2025. EPS moved from C¥0.0521 to C¥0.0243 across the 2024 halves before landing at C¥0.0517 in the latest half, which frames the earnings path you are reacting to today. With...

Alvotech has published its 2025 Annual Report and filed its Form 20-F, detailing progress in its biosimilar portfolio, including five approved products and a pipeline of nine additional candidates supported by global commercial partnerships. The company also reaffirmed its 2026 revenue guidance of US$650 million to US$700 million, highlighting a focus on cash flow and margin expansion through sales growth and operational efficiencies. With reaffirmed 2026 revenue guidance and expanded...

China Communications Services (SEHK:552) has put fresh numbers on the table for FY 2025, with first half revenue of C¥76.9b and basic EPS of C¥0.31 setting the tone against a trailing 12 month revenue base of about C¥150.1b and EPS of roughly C¥0.52. The company has seen revenue move from C¥74.4b in the first half of 2024 to C¥76.9b in the first half of 2025, while basic EPS has stayed close to the C¥0.31 mark over that period. This gives a clearer view of both business scale and per share...

Why recent headlines may not tell you the full story on Stride Stride attracts a lot of attention from investors wondering if the current share price reflects its underlying value or if there is a disconnect to unpack. The stock closed at US$88.17 recently, with returns of 1.6% over 7 days, 4.5% over 30 days, 36.5% year to date and a 31.7% decline over the last 12 months, while the 3 year and 5 year returns sit at 129.3% and 167.7% respectively. Recent news coverage has focused on Stride's...

CMBC Capital Holdings (SEHK:1141) has just posted its FY 2025 numbers, reporting first half revenue of HK$228.2 million and net income of HK$117.9 million. This translates into basic EPS of HK$0.107 per share. The company’s revenue moved from HK$190.6 million and EPS of HK$0.071 in the first half of FY 2024 to HK$228.2 million and HK$0.107 in the latest half. The trailing twelve month EPS is HK$0.138 on revenue of HK$370.4 million and net income of HK$151.2 million, which brings attention to...

Missiles struck the Neot Hovav industrial zone in Israel, home to one of NYSE:TEVA’s largest manufacturing facilities. Emergency responses were triggered as authorities assessed damage and safety risks across the zone. Initial indications point to limited direct damage to Teva’s operations, but the incident highlighted exposure to geopolitical and physical threats. The event raised questions about operational continuity, supply chain reliability, and regulatory oversight for sites handling...

China Renaissance Holdings (SEHK:1911) has reported FY 2025 first half revenue of C¥509 million and basic EPS of C¥0.13, with investors focused on how this compares with the recent trailing 12 month EPS of C¥0.19. The company has seen revenue move from C¥351.8 million and C¥471.7 million in the first and second halves of 2024 to the current C¥509 million, while EPS has shifted from losses of C¥0.15 and C¥0.20 per share in those periods to a positive C¥0.13. This sets the stage for a closer...

China Glass Holdings (SEHK:3300) has reported FY 2025 first half revenue of C¥2,153.5 million with a basic EPS loss of C¥0.15, while trailing twelve month figures show revenue of C¥5,207.6 million and basic EPS of C¥0.06. Over recent half year periods, the company has seen revenue move from C¥2,683.5 million in 1H FY 2024 to C¥3,054.1 million in 2H FY 2024 and then to C¥2,153.5 million in 1H FY 2025. Over the same intervals, EPS shifted from a loss of C¥0.07 to a loss of C¥0.45 and then to a...

China Ruyi Holdings (SEHK:136) has put up a clean headline for FY 2025, with first half revenue of C¥2.2b and basic EPS of C¥0.08, after reporting losses in both halves of FY 2024. The company has seen total revenue edge from about C¥1.8b in each half of FY 2024 to C¥2.2b in the first half of FY 2025, while net income has moved from losses of C¥115m and C¥76m in FY 2024 to a profit of C¥1.2b, pointing to a sharp reset in margins that puts profitability back at the center of the story. See our...

Hangzhou Jiuyuan Genetic Biopharmaceutical (SEHK:2566) has put fresh FY 2025 numbers on the table, with first half revenue of C¥638.8 million and basic EPS of C¥0.37 setting the tone for how the year is shaping up. Over recent halves the company has seen revenue move from C¥702.4 million and EPS of C¥0.53 in 1H 2024 to C¥666.8 million and EPS of C¥0.16 in 2H 2024, giving investors a clear view of how the current run rate compares with recent history. With trailing 12 month net profit margins...

Wondering whether BlackBerry at around US$4.51 is a bargain or a value trap? This article breaks down what the current share price might be implying about the company. The stock has returned 1.1% over the last 7 days, but is down 2.6% over 30 days, 13.6% year to date, 15.7% over 1 year, 27.3% over 3 years and 60.1% over 5 years. This raises questions about how the market is pricing its prospects. Recent coverage has focused on BlackBerry's ongoing shift from its hardware roots to software...

What ARMOUR Residential REIT’s Recent Returns Tell You ARMOUR Residential REIT (ARR) has seen mixed share performance recently, with a 3.3% gain over the past day and 4.3% over the past week, but a 7.1% decline over the past month. See our latest analysis for ARMOUR Residential REIT. At a share price of $16.68, ARMOUR Residential REIT’s recent 1 day and 7 day share price gains sit against a weaker year to date share price return and a positive 1 year total shareholder return. This points to...

Greentown China Holdings (SEHK:3900) has just reported FY 2025 results with first half revenue of C¥53.4b and basic EPS of C¥0.08, setting a restrained tone after a mixed prior year. Over the past three reported half year periods, revenue moved from C¥69.6b in 1H 2024 to C¥88.0b in 2H 2024 and now C¥53.4b in 1H 2025, while basic EPS shifted from C¥0.81 to a loss of C¥0.18 and then to C¥0.08. This has left investors focused squarely on how thin margins and volatile earnings shape the...

Vera Therapeutics has appointed Jane Wright-Mitchell as its new Chief Legal Officer. Wright-Mitchell brings extensive legal, compliance, and intellectual property experience in life sciences and pharmaceuticals. The appointment adds senior leadership depth as Vera Therapeutics continues to develop its pipeline. The new Chief Legal Officer steps in at a time when Vera Therapeutics, listed as NasdaqGM:VERA, is trading at $40.23. The share price reflects a mixed return profile, with a 1.2%...